School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo

JAMA - Journal of the American Medical Association

Volumn 312, Issue 11, 2014, Pages 1105-1113

  Doyle, Lex W ^a,b,c   Anderson, Peter J ^a,b,c   Haslam, Ross ^d,e   Lee, Katherine J ^a,c   Crowther, Caroline ^d,f,g   Darlow, Brian ^h   Austin, Nicola ^h   French, Noel ⁱ   Campbell, Catherine ⁱ   Carse, Elizabeth ^j   Hayes, Marie ^j   Harding, Jane ^k   McKinlay, Chris ^k   Bevan, Coila ^k   De Paoli, Antonio ^l   Sutton, Lee ^m   Rieger, Ingrid ⁿ   Wocadlo, Crista ⁿ   Colditz, Paul ^o   Pritchard, Margo ^o   Gray, Peter H ^p   Watkins, Andrew ^q   Opie, Gillian ^q   Kelly, Elaine ^q   Woods, Heather ^q   Callanan, Catherine ^b   Davis, Noni ^b   Duff, Julianne ^b   Weston, Phil ^r   Ashwood, Pat ^d   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h CHRISTCHURCH WOMEN S HOSPITAL   (New Zealand)

ⁱ KING EDWARD MEMORIAL HOSPITAL   (Australia)

^j MONASH MEDICAL CENTRE   (Australia)

^k NATIONAL WOMEN S HOSPITAL   (New Zealand)

^l ROYAL HOBART HOSPITAL   (Australia)

^m ROYAL HOSPITAL FOR WOMEN   (Australia)

ⁿ ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^o UNIVERSITY OF QUEENSLAND   (Australia)

^p Mater Mothers Hospitals   (Australia)

^q MERCY HOSPITAL FOR WOMEN   (Australia)

^r WAIKATO HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; PLACEBO; NEUROPROTECTIVE AGENT;

ACADEMIC ACHIEVEMENT; ARTICLE; ATTENTION; AUSTRALIA; CEREBRAL PALSY; CHILD; CHILD BEHAVIOR; CHILD GROWTH; CHILDHOOD MORTALITY; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FETUS; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; INTELLIGENCE QUOTIENT; MALE; MOTOR PERFORMANCE; NEW ZEALAND; PREGNANT WOMAN; PREMATURITY; PRENATAL CARE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; CHILD DEVELOPMENT; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; INFANT MORTALITY; MULTICENTER STUDY; NEWBORN; PREGNANCY; PSYCHOMOTOR DISORDER; TREATMENT OUTCOME;

CEREBRAL PALSY; CHILD DEVELOPMENT; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MAGNESIUM SULFATE; MALE; MOTOR SKILLS DISORDERS; NEUROPROTECTIVE AGENTS; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; TREATMENT OUTCOME;

EID: 84907195512     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.11189     Document Type: Article

References (35)

1. Doyle LW, Roberts G, Anderson PJ; Victorian Infant Collaborative Study Group. Outcomes at age 2 years of infants <28 weeks' gestational age born in Victoria in 2005. J Pediatr. 2010;156(1):49-53, e1.
2. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025.
3. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2002;(4):CD001060.
4. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1):CD004661.
5. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: national clinical practice guidelines. Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel. http://www.nhmrc.gov.au/guidelines/publications/cp128. Accessed August 26, 2014.
6. Magee L, Sawchuck D, Synnes A, von Dadelszen P. SOGC Clinical Practice Guideline: magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 2011;33(5):516-529.
7. Marret S, Doyle LW, Crowther CA, Middleton P. Antenatal magnesium sulphate neuroprotection in the preterm infant. Semin Fetal Neonatal Med. 2007;12(4):311-317.
8. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 1995;95(2):263-269.
9. Crowther CA, Hiller JE, Doyle LW, Haslam RR; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290(20):2669-2676.
10. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371(9608):261-269.
11. Rickards AL, Kitchen WH, Doyle LW, Kelly EA. Correction of developmental and intelligence test scores for premature birth. Aust Paediatr J. 1989;25(3):127-129.
12. Wilson-Ching M, Pascoe L, Doyle LW, Anderson PJ. The effects of correcting for prematurity on cognitive test scores in childhood. J Paediatr Child Health. 2014;50(3):182-188.
13. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-223.
14. Henderson SE, Sugden DA. Movement Assessment Battery for Children. Sidcup, Kent: Psychological Corp; Harcourt Brace Jovanovich; 1988.
15. Henderson SE, Sugden DA, Barnett A. Movement Assessment Battery for Children. 2nd ed. Sidcup, Kent: Harcourt Assessment; 2007.
16. Wechsler D. WISC-IV: Administration and Scoring Manual. San Antonio, TX: Psychological Corp; 2003.
17. Wilkinson G. WRAT3 Wide Range Achievement Test. Wilmington, VA:Wide Range; 1993.
18. Mulder H, Pitchford NJ, Hagger MS, Marlow N. Development of executive function and attention in preterm children: a systematic review. Dev Neuropsychol. 2009;34(4):393-421.
19. Anderson PJ, De Luca CR, Hutchinson E, Spencer-Smith MM, Roberts G, Doyle LW; Victorian Infant Collaborative Study Group. Attention problems in a representative sample of extremely preterm/extremely low birth weight children. Dev Neuropsychol. 2011;36(1):57-73.
20. Manly T, Robertson I, Anderson V, Nimmo-Smith I. The Test of Everyday Attention for Children. Suffolk, UK: Thames Valley Test Co; 1999.
21. Rey A. Psychological examination of traumatic encephalopathy [in French]. Arch Psychol. 1941;28:286-340.
22. Rey A. Psychological examination of traumatic encephalopathy [translation]. Clin Neuropsychol. 1993;7:3-21.
23. Osterrieth P. The complex figure copy test [in French]. Arch Psychol. 1944;30:206-256.
24. Osterrieth P. The complex figure copy test [translation]. Clin Neuropsychol. 1993;7:3-21.
25. Gioia G, Isquith P, Guy S. Assessment of executive functions in children with neurological impairment. In: Simeonsson R, Rosenthal S, eds. Psychological and Developmental Assessment: Children With Disabilities and Chronic Conditions. New York, NY: Guildford Press; 2001:317-356.
26. Conners C. Conners' Teacher Rating Scales-Revised. North Tonawanda, NY: Multi-Health Systems; 1997.
27. Goodman A, Goodman R. Strengths and difficulties questionnaire as a dimensional measure of child mental health. J Am Acad Child Adolesc Psychiatry. 2009;48(4):400-403.
28. Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med. 1998;17(4):407-429.
29. Saigal S, Rosenbaum P, Stoskopf B, et al. Comprehensive assessment of the health status of extremely low birth weight children at eight years of age: comparison with a reference group. J Pediatr. 1994;125(3):411-417.
30. Waters E, Salmon L, Wake M, Hesketh K, Wright M. The Child Health Questionnaire in Australia: reliability, validity and population means. Aust N Z J Public Health. 2000;24(2):207-210.
31. Roberts G, Anderson PJ, Doyle LW; Victorian Infant Collaborative Study Group. Neurosensory disabilities at school age in geographic cohorts of extremely low birth weight children born between the 1970s and the 1990s. J Pediatr. 2009;154(6):829-834.
32. Roberts G, Anderson PJ, De Luca C, Doyle LW; Victorian Infant Collaborative Study Group. Changes in neurodevelopmental outcome at age eight in geographic cohorts of children born at 22-27 weeks' gestational age during the 1990s. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F90-F94.
33. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: Psychological Corp; 1993.
34. Callanan C, Doyle L, Rickards A, Kelly E, Ford G, Davis N. Children followed with difficulty: how do they differ? J Paediatr Child Health. 2001;37(2):152-156.
35. Crowther CA, Middleton PF, Bain E, et al WISH Project Team. Working to improve survival and health for babies born very preterm: the WISH Project protocol. BMC Pregnancy Childbirth. 2013;13:239.